Neuronetics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the Annual Meeting of Stockholders held by Neuronetics, Inc. on May 28, 2026. The filing details the voting outcomes for four specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 55,950,118 shares were represented at the meeting, constituting approximately 80.41% of eligible shares and establishing a quorum. The results for the proposals were as follows:
- Proposal 1 (Election of Directors): All seven nominees were elected to one-year terms. Notable vote counts included Daniel L. Reuvers (34,472,656 For) and Sasha S. Cucuz (28,512,554 For). There were 14,661,594 broker non-votes for each nominee.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of KPMG LLP for the fiscal year ending December 31, 2026, with 47,194,967 votes For and 6,924,816 votes Against.
- Proposal 3 (Say-on-Pay): The advisory approval of executive compensation for 2025 was ratified with 29,133,360 votes For and 11,503,294 votes Against.
- Proposal 4 (2026 Equity Incentive Plan): The plan was approved with 23,802,955 votes For and 16,651,661 votes Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to confirm the 80.41% participation rate.
- Review the specific terms of the newly approved 2026 Equity Incentive Plan.
- Monitor the "Against" vote percentages for the Say-on-Pay and Equity Plan proposals, which were significant relative to the "For" votes.
- Confirm the tenure of the newly elected directors, which extends until the 2027 Annual Meeting.